A 1970 article describes the use of LSD in psychedelic therapy for cancer patients. The authors report that LSD-assisted therapy can produce profound psychological experiences that help patients confront existential distress, reduce anxiety and depression, and improve their quality of life during terminal illness. The therapy involves carefully controlled sessions with psychological support. The text suggests that such treatment may lead to lasting positive changes in patients' attitudes toward death and their remaining time. However, the article is a clinical description and case report, not a controlled trial, and the findings are based on the authors' clinical observations rather than systematic data.
A pilot project with thirty cancer patients experiencing psychological distress combined about twelve hours of conventional verbal psychotherapy over four weeks with a single intensive drug-assisted therapy session using dipropyltryptamine (DPT), a short-acting psychedelic. Analysis of psychological tests and independent ratings before and after the intervention suggests the total therapeutic approach enhances quality of life. The text discusses the relative merits of DPT compared to LSD and the need for a controlled study.